Assessment of Hepatocellular Carcinoma Awareness and Understanding Among Health Science Students: A Cross-Sectional Study
Abstract
1. Introduction

2. Materials and Methods
2.1. Study Design
2.2. Study Setting and Population
2.3. Inclusion and Exclusion Criteria
2.4. Sample Size
2.5. Data Collection Tool
2.6. Statistical Analysis
2.7. Ethical Approval and Consent
3. Results
Number of Participants Invited to the Final Sample
4. Discussion
4.1. Study Limitations
4.2. Future Directions
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Chidambaranathan-Reghupaty, S.; Fisher, P.B.; Sarkar, D. Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv. Cancer Res. 2021, 149, 1–61. [Google Scholar] [CrossRef]
- Gong, J.; Tu, W.; Liu, J.; Tian, D. Hepatocytes: A key role in liver inflammation. Front. Immunol. 2023, 13, 1083780. [Google Scholar] [CrossRef]
- Llovet, J.M.; Kelley, R.K.; Villanueva, A.; Singal, A.G.; Pikarsky, E.; Roayaie, S.; Lencioni, R.; Koike, K.; Zucman-Rossi, J.; Finn, R.S. Hepatocellular carcinoma. Nat. Rev. Dis. Primers 2021, 7, 6. [Google Scholar] [CrossRef] [PubMed]
- McGlynn, K.A.; Petrick, J.L.; El-Serag, H.B. Epidemiology of Hepatocellular Carcinoma. Hepatology 2021, 73 (Suppl. 1), 4–13. [Google Scholar] [CrossRef] [PubMed]
- Valery, P.C.; Laversanne, M.; Clark, P.J.; Petrick, J.L.; McGlynn, K.A.; Bray, F. Projections of primary liver cancer to 2030 in 30 countries worldwide. Hepatology 2018, 67, 600–611. [Google Scholar] [CrossRef]
- Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed]
- Kulik, L.; El-Serag, H.B. Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology 2019, 156, 477–491.e1. [Google Scholar] [CrossRef]
- Cancer Incidence Report Saudi Arabia 2020. Available online: https://shc.gov.sa/Arabic/NCC/Activities/AnnualReports/Cancer%20Incidence%20Report%202020.pdf (accessed on 20 January 2025).
- Polesel, J.; Zucchetto, A.; Montella, M.; Maso, L.D.; Crispo, A.; La Vecchia, C.; Serraino, D.; Franceschi, S.; Talamini, R. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann. Oncol. 2009, 20, 353–357. [Google Scholar] [CrossRef]
- Kew, M. Hepatocellular carcinoma: Epidemiology and risk factors. J. Hepatocell. Carcinoma 2014, 1, 115–125. [Google Scholar] [CrossRef]
- Janevska, D.; Chaloska-Ivanova, V.; Janevski, V. Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment. Open Access Maced. J. Med. Sci. 2015, 3, 732–736. [Google Scholar] [CrossRef]
- Karageorgos, S.A. Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: A 25-year study. Ann. Gastroenterol. 2017, 30, 357–363. [Google Scholar] [CrossRef] [PubMed]
- Nault, J.C. Pathogenesis of hepatocellular carcinoma according to aetiology. Best Pr. Res. Clin. Gastroenterol. 2014, 28, 937–947. [Google Scholar] [CrossRef]
- Schulze, K.; Imbeaud, S.; Letouzé, E.; Alexandrov, L.B.; Calderaro, J.; Rebouissou, S.; Couchy, G.; Meiller, C.; Shinde, J.; Soysouvanh, F.; et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat. Genet. 2015, 47, 505–511. [Google Scholar] [CrossRef] [PubMed]
- Schulze, K.; Nault, J.-C.; Villanueva, A. Genetic profiling of hepatocellular carcinoma using next-generation sequencing. J. Hepatol. 2016, 65, 1031–1042. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.M.; Kim, S.Y.; Seki, E. Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets. Semin. Liver Dis. 2019, 39, 26–42. [Google Scholar] [CrossRef] [PubMed]
- Refolo, M.G.; Messa, C.; Guerra, V.; Carr, B.I.; D’alessandro, R. Inflammatory Mechanisms of HCC Development. Cancers 2020, 12, 641. [Google Scholar] [CrossRef]
- Khaled, J.; Kopsida, M.; Lennernäs, H.; Heindryckx, F. Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma. Cells 2022, 11, 632. [Google Scholar] [CrossRef]
- Fan, Z.; Duan, J.; Wang, L.; Xiao, S.; Li, L.; Yan, X.; Yao, W.; Wu, L.; Zhang, S.; Zhang, Y.; et al. PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling. Cancer Lett. 2019, 450, 132–143. [Google Scholar] [CrossRef]
- Ferrín, G.; Guerrero, M.; Amado, V.; Rodríguez-Perálvarez, M.; De la Mata, M. Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma. Int. J. Mol. Sci. 2020, 21, 1266. [Google Scholar] [CrossRef]
- Tan, C.; Goh, G.B.; Youn, J.; Yu, J.C.; Singh, S. Public awareness and knowledge of liver health and diseases in Singapore. J. Gastroenterol. Hepatol. 2021, 36, 2292–2302. [Google Scholar] [CrossRef]
- Mohamed, R.; Yip, C.; Singh, S. Understanding the knowledge, awareness, and attitudes of the public towards liver diseases in Malaysia. Eur. J. Gastroenterol. Hepatol. 2023, 35, 742–752. [Google Scholar] [CrossRef]
- Patel, N.; Yopp, A.C.; Singal, A.G. Diagnostic Delays Are Common Among Patients with Hepatocellular Carcinoma. J. Natl. Compr. Cancer Netw. JNCCN 2015, 13, 543–549. [Google Scholar] [CrossRef] [PubMed]
- Schlachterman, A. Current and future treatments for hepatocellular carcinoma. World J. Gastroenterol. 2015, 21, 8478–8491. [Google Scholar] [CrossRef]
- International Agency for Research on Cancer, Cancer Today, 2024. Age-Standardized Rate per 100,000, Incidence and Mortality, Both Sexes, in 2022, Saudi Arabia. Globocan 2022 (Version 1.1). 2024. Available online: https://gco.iarc.fr/today/en/dataviz/bars?types=0_1&mode=cancer&group_populations=1&populations=682&sort_by=value1 (accessed on 20 January 2025).
- Albishi, A.M.; Alshahrani, A.; Alshahrani, A.M.; Alahmari, D.M.; Alqibti, H.M.; Alsharif, M.A.; Alshahrani, S.M.; Alqahtani, M.S.; Alqahtani, I.A.S. Public Awareness of Hepatocellular Carcinoma and its Risk Factors Among General Population in Southern Region, Saudi Arabia, Cross Sectional Study. Int. J. Med. Res. Health Sci. 2020, 9, 46–53. [Google Scholar]
- Yang, J.D.; Hainaut, P.; Gores, G.J.; Amadou, A.; Plymoth, A.; Roberts, L.R. A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 589–604. [Google Scholar] [CrossRef]
- Fujiwara, N.; Friedman, S.L.; Goossens, N.; Hoshida, Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J. Hepatol. 2018, 68, 526–549. [Google Scholar] [CrossRef]
- Bittencourt, L.R.A.; Santos-Silva, R.; Taddei, J.A.; Andersen, M.L.; de Mello, M.T.; Tufik, S. Sleep complaints in the adult Brazilian population: A national survey based on screening questions. J. Clin. Sleep Med. 2009, 5, 459–463. [Google Scholar] [CrossRef] [PubMed]
- Bittencourt, P.L.; Codes, L.; Cesar, H.F.; Ferraz, M.L.G. Public knowledge and attitudes toward liver diseases and liver cancer in the Brazilian population: A cross sectional study. Lancet Reg. Health Am. 2023, 23, 100531. [Google Scholar] [CrossRef]
- Vu, N.T.H.; Tran, T.T.T.; Quach, D.T.; Miyauchi, S.; Yoshida, M.; Okamoto, Y.; Lu, D.M.; Le Tran, L.; Luu, M.N.; Hiyama, T. Knowledge of common cancers among new-entry health science students in Japan and Vietnam. BMC Med. Educ. 2023, 23, 724. [Google Scholar] [CrossRef]
- Khalili, M.; Guy, J.; Yu, A.; Li, A.; Diamond-Smith, N.; Stewart, S.; Chen, M.; Nguyen, T. Hepatitis B and Hepatocellular Carcinoma Screening Among Asian Americans: Survey of Safety Net Healthcare Providers. Dig. Dis. Sci. 2011, 56, 1516–1523. [Google Scholar] [CrossRef]
- He, W.-J.; Xu, M.-Y.; Xu, R.-R.; Zhou, X.-Q.; Ouyang, J.-J.; Han, H.; Chen, G.-Z. Inpatients’ knowledge about primary liver cancer and hepatitis. Asian Pac. J. Cancer Prev. 2013, 14, 4913–4918. [Google Scholar] [CrossRef] [PubMed]
- Alshammari, F.D.; Ahmed, H.G.; Alshammari, D.; Alharbi, A.M.; Alsaedi, A.S.; Elasbaly, A. Population insight of the relationship between lifestyle and cancer: A population-based survey. AIMS Public Health 2019, 6, 34–48. [Google Scholar] [CrossRef] [PubMed]
- Shaw, J.; Patidar, K.R.; Reuter, B.; Hajezifar, N.; Dharel, N.; Wade, J.B.; Bajaj, J.S. Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy. Dig. Dis. Sci. 2021, 66, 2603–2609. [Google Scholar] [CrossRef] [PubMed]
- Jiffry, B.; Neyaz, Y.; Softah, A.; Alqahtani, N. Public knowledge and awareness of hepatocellular carcinoma among the Saudi Arabian population. Int. J. Med. Dev. Ctries. 2022, 6, 1227–1234. [Google Scholar] [CrossRef]
- Cohen, S.A.; Cohen, L.E.; Tijerina, J.D. The impact of monthly campaigns and other high-profile media coverage on public interest in 13 malignancies: A Google Trends analysis. Ecancermedicalscience 2020, 14, 1154. [Google Scholar] [CrossRef]


| Variable | All Participants (n = 411) | |||
|---|---|---|---|---|
| Weighted | % | Unweighted | ||
| Age | ≤24 | 376 | 91.48% | 377 |
| >24 | 35 | 8.52% | 34 | |
| Gender | Female | 227 | 55.20% | 230 |
| Male | 184 | 44.80% | 181 | |
| Marital status | Single | 350 | 85.10% | 349 |
| Married | 61 | 14.90% | 62 | |
| Residency | Rural | 239 | 58.30% | 236 |
| Urban | 172 | 41.70% | 175 | |
| Education level | Undergraduate | 407 | 99.00% | 407 |
| Post graduate | 4 | 1.00% | 4 | |
| College/program of study | Medical/Dental | 51 | 12.30% | 52 |
| Allied and Health Sciences | 360 | 87.70% | 359 | |
| Year of study | 1st | 48 | 11.60% | 47 |
| 2nd | 153 | 37.30% | 145 | |
| 3rd | 72 | 17.50% | 74 | |
| ≥4th | 138 | 33.50% | 145 | |
| Have any of your family or friends had liver cirrhosis or any liver diseases? | No | 384 | 93.50% | 384 |
| Yes | 27 | 6.50% | 27 | |
| Have any of your family or friends had hepatocellular cancer or any other cancer? | No | 312 | 76.00% | 313 |
| Yes | 99 | 24.00% | 98 | |
| Variable | All Participants (n = 411) | |||
|---|---|---|---|---|
| Weighted | % | Unweighted | ||
| Do you know the primary functions of the liver? | No | 30 | 7.40% | 29 |
| Yes | 381 | 92.60% | 382 | |
| Have you heard of hepatocellular cancer before taking this survey? | No | 184 | 44.80% | 177 |
| Yes | 227 | 55.20% | 234 | |
| Are you aware of the screening methods used to detect hepatocellular cancer? | No | 264 | 64.20% | 251 |
| Yes | 147 | 35.80% | 160 | |
| Which of the following screening tools do you believe could be employed for the detection of hepatocellular carcinoma? (Select all that apply) | Alpha-fetoprotein | 5 | 1.10% | 5 |
| CT and MRI Scan | 68 | 16.40% | 67 | |
| Liver Biopsy | 29 | 7.00% | 28 | |
| Liver function | 273 | 66.40% | 275 | |
| Liver ultrasound | 24 | 5.80% | 24 | |
| X-ray of the ab | 13 | 3.20% | 12 | |
| When do you believe it is appropriate for someone to undergo screening for hepatocellular carcinoma? | 40–49 Years | 74 | 17.90% | 76 |
| 50–59 Years | 50 | 12.10% | 51 | |
| ≥60 Years | 29 | 6.90% | 30 | |
| When risk factors present | 94 | 22.80% | 94 | |
| When signs & symptoms appear | 165 | 40.20% | 160 | |
| Do you believe that Hepatocellular Carcinoma can be prevented? | No | 12 | 2.90% | 12 |
| I don’t know | 161 | 39.30% | 158 | |
| Yes | 238 | 57.80% | 241 | |
| Are you familiar with any preventive measures to reduce the risk of hepatocellular cancer? | No | 213 | 51.80% | 203 |
| Yes | 198 | 48.20% | 208 | |
| Which of the following are effective preventive measures for hepatocellular cancer? (Select all that apply) | Hepatitis B Vaccination | 314 | 76.50% | 312 |
| No Alcohol/Smoking | 79 | 19.20% | 82 | |
| Regular Exercise | 16 | 3.80% | 15 | |
| Regular liver check-up | 2 | 0.50% | 2 | |
| Do you believe public awareness campaigns about Hepatocellular cancer are essential for early detection and prevention? | No | 14 | 3.30% | 14 |
| Yes | 397 | 96.70% | 397 | |
| Do you think hepatocellular cancer is treatable? | No | 31 | 7.60% | 31 |
| I don’t know | 171 | 41.70% | 165 | |
| Yes | 208 | 50.70% | 215 | |
| Which of the following treatment options for hepatocellular carcinoma you are aware of? | Chemotherapy | 86 | 21.00% | 86 |
| Radiationtherapy | 21 | 5.20% | 21 | |
| Immunizationtherapy | 4 | 1.00% | 4 | |
| Liver transplantation | 51 | 12.40% | 52 | |
| Surgery | 66 | 16.10% | 69 | |
| All of the above | 182 | 44.30% | 179 | |
| Where did you acquire most of your knowledge about hepatocellular carcinoma? | Cancer Awareness | 55 | 13.50% | 51 |
| Curriculum/Text books | 203 | 49.50% | 207 | |
| TV Programs/Social | 61 | 14.90% | 60 | |
| Websites | 91 | 22.10% | 93 | |
| Variable | All Participants (n = 411) | Awareness Good (n = 206) | OR § | 95% CI | ||
|---|---|---|---|---|---|---|
| LL | UL | |||||
| Age | ≤24 | 376 | 190 | - | - | - |
| >24 | 35 | 16 | 1.91 | 0.8 | 4.57 | |
| Gender | Female | 227 | 124 | - | - | - |
| Male | 184 | 82 | 1.94 ** | 1.24 | 3.03 | |
| Marital status | Single | 350 | 173 | - | - | - |
| Married | 61 | 33 | 1.07 | 0.55 | 2.06 | |
| Residency | Rural | 239 | 109 | - | - | - |
| Urban | 172 | 97 | 1.34 | 0.86 | 2.08 | |
| Education level | Undergraduate | 407 | 204 | - | - | - |
| Post graduate | 4 | 2 | 1.56 | 0.18 | 13.85 | |
| College/program of study | Medical/Dental | 51 | 29 | 1.34 | 0.66 | 2.72 |
| Allied and Health Sciences | 360 | 176 | - | - | - | |
| Year of study | 1st | 48 | 22 | - | - | - |
| 2nd | 153 | 50 | 0.61 | 0.31 | 1.21 | |
| 3rd | 72 | 42 | 1.94 ** | 0.89 | 4.21 | |
| ≥4th | 138 | 92 | 2.83 ** | 1.39 | 5.77 | |
| Have any of your family or friends had liver cirrhosis or any liver diseases? | No | 384 | 192 | - | - | - |
| Yes | 27 | 14 | 1.03 | 0.63 | 1.68 | |
| Have any of your family or friends had hepatocellular cancer or any other cancer? | No | 312 | 158 | - | - | - |
| Yes | 99 | 47 | 1.06 | 0.43 | 2.57 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hakami, Z.H. Assessment of Hepatocellular Carcinoma Awareness and Understanding Among Health Science Students: A Cross-Sectional Study. Healthcare 2025, 13, 2669. https://doi.org/10.3390/healthcare13212669
Hakami ZH. Assessment of Hepatocellular Carcinoma Awareness and Understanding Among Health Science Students: A Cross-Sectional Study. Healthcare. 2025; 13(21):2669. https://doi.org/10.3390/healthcare13212669
Chicago/Turabian StyleHakami, Zaki H. 2025. "Assessment of Hepatocellular Carcinoma Awareness and Understanding Among Health Science Students: A Cross-Sectional Study" Healthcare 13, no. 21: 2669. https://doi.org/10.3390/healthcare13212669
APA StyleHakami, Z. H. (2025). Assessment of Hepatocellular Carcinoma Awareness and Understanding Among Health Science Students: A Cross-Sectional Study. Healthcare, 13(21), 2669. https://doi.org/10.3390/healthcare13212669
